Tag: Atherosclerosis

Clazakizumab improves albumin and inflammation in participants undergoing haemodialysis

Trial
Phase 2, POSIBIL6ESKD
Conference
ERA 2024
Type
News article

20 June 2024 18:33

REPRIEVE: Mechanisms behind MACE reduction in HIV population on pitavastatin

Presented By
Dr Michael Lu, Massachusetts General Hospital, USA
Trial
Phase 3, REPRIEVE
Conference
AHA 2023
Type
Peer-reviewed article

29 January 2024 14:31

Cardiovascular disease and diabetes: new guidelines

Presented By
Prof. Emanuele Di Angelantonio; Prof. Nikolaus Marx; Dr Katharina Schuett; Prof. Dirk Müller-Wieland; Prof. Bianca Rocca
Conference
ESC 2023
Type
Peer-reviewed article

30 October 2023 16:02

Multifaceted strategy improves prescription of therapies for diabetes and ASCVD

Presented By
Prof. Neha Pagidipati, Duke University Hospital, NC, USA
Trial
COORDINATE-Diabetes
Conference
ACC 2023
Type
Peer-reviewed article

7 June 2023 09:55

Key correlates of incident dementia identified in the MESA study

Presented By
Dr Mohammad Ostovaneh, Johns Hopkins Hospital, MD, USA
Trial
MESA
Conference
ACC 2023
Type
Peer-reviewed article

7 June 2023 09:03

Olpasiran leads to dramatic reductions in Lp(a) concentrations

Presented By
Prof. Michelle O´Donoghue, Brigham and Women's Hospital, MA, USA
Trial
Phase 2, OCEAN(a)-DOSE
Conference
AHA 2023
Type
Peer-reviewed article

11 January 2023 12:50

Dietary supplements not effective in lowering LDL-C, use of low-dose statins encouraged

Presented By
Dr Luke Laffin, Cleveland Clinic, OH, USA
Trial
SPORT
Conference
AHA 2022
Type
Peer-reviewed article

11 January 2023 12:45

AHA 2022 Highlights Podcast

Presented By
Robert van den Heuvel, Medicom
Conference
AHA 2022

28 November 2022 13:03

Inclisiran Lowers Cholesterol Across All BMI groups

Expert
Dr Lawrence A. Leiter, Clinical Nutrition and Risk Factor Modification Centre
Conference
AHA 2021

3 February 2022 08:52

2021 ESC Guidelines on Cardiovascular Disease Prevention

Presented By
Prof. Frank Visseren, Guidelines Task Force Chair
Conference
ESC 2021
Type
Peer-reviewed article

26 October 2021 11:52

No difference in ischaemic risk or bleeding with low vs high-dose aspirin for secondary prevention: Lessons and questions from the ADAPTABLE trial

Presented By
Prof. William Schuyler Jones , Duke Clinical Research Institute, USA
Trial
ADAPTABLE
Conference
ACC 2021
Type
Peer-reviewed article

9 July 2021 23:03

Lower burden of high-risk atherosclerotic plaques in psoriasis patients treated with biologics

Presented By
Prof. Nehal N. Mehta, National Heart, Lung, and Blood Institute, MD, USA
Conference
AAD VMX 2021
Type
Peer-reviewed article

7 June 2021 13:30

Ticagrelor/aspirin reduces stroke risk in patients with ipsilateral cervicocranial plaque

Presented By
Prof. Pierre Amarenco, Paris University, France
Trial
THALES
Conference
AHA 2020

18 February 2021 11:01

Safety and efficacy of inclisiran for hypercholesterolemia

Presented By
Prof. R. Scott Wright, Mayo Clinic, USA
Trial
Phase 3, ORION
Conference
AHA 2020
Type
Peer-reviewed article

17 February 2021 14:37

Remote risk management programme effective and efficient

Presented By
Prof. Benjamin Scirica, Brigham and Women’s Hospital, USA
Conference
AHA 2020
Type
Peer-reviewed article

17 February 2021 14:31

Reduced progression of coronary atherosclerosis with icosapent ethyl

Presented By
Prof. Matthew Budoff, Harbor-UCLA Medical Center, USA
Trial
EVAPORATE trial
Conference
ESC 2020
Type
Peer-reviewed article

5 November 2020 12:48

SGLT2 inhibitor ertugliflozin shows similar mortality but fewer HF hospitalisations

Presented By
Prof. Francesco Cosentino, Karolinska University Hospital, Sweden
Trial
VERTIS CV
Conference
ESC 2020
Type
Peer-reviewed article

5 November 2020 12:39

Icosapent ethyl plus statins reduces total plaque volume

Presented By
Prof. Matthew J. Budoff, UCLA, USA
Trial
EVAPORATE
Conference
AHA 2019
Type
Peer-reviewed article

26 February 2020 20:55

Complete revascularisation for obstructive non-culprit lesions with vulnerable plaque

Presented By
Dr Natalia Pinilla-Echeverri, McMaster University, Canada
Trial
COMPLETE
Conference
AHA 2019
Type
Peer-reviewed article

26 February 2020 18:02

Inclisiran safely halves LDL-Cholesterol

Presented By
Prof. R. Scott Wright, Mayo Clinic, Rochester, USA
Trial
ORION-10
Conference
AHA 2019
Type
Peer-reviewed article

26 February 2020 14:51

New guidelines on the prevention of cardiovascular conditions

Presented By
Prof. Roger S. Blumenthal, Johns Hopkins University, USA
Conference
AHA 2019
Type
Peer-reviewed article

26 February 2020 14:36

Patients with polyvascular disease significantly undertreated with lipid lowering therapies

Conference
ACC 2019
Type
Peer-reviewed article

4 June 2019 15:12

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease

Conference
ACC 2019
Type
Peer-reviewed article

4 June 2019 13:30
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com